about
Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalitiesPolymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: the Fukuoka Stroke Registry and the Hisayama study.Novel avenues of drug discovery and biomarkers for diabetes mellitus.Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes.The association of obesity with insulin resistance in male patients with obstructive sleep apnea syndrome in Korea.Metabolic rehabilitation: science gathers to support a new intervention to prevent stroke.Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults.Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.Mammalian target of rapamycin signaling in diabetic cardiovascular diseaseStroke in patients with diabetes and hypertension.Should we quantify insulin resistance in patients with renal disease?Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitusMechanistic insights into diabetes mellitus and oxidative stressThe Influence of Acute Hyperglycemia in an Animal Model of Lacunar Stroke That Is Induced by Artificial Particle Embolization.Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.Metabolic syndrome and stroke.Secondary prevention of atherothrombotic events after ischemic stroke.Risk factor management to prevent first stroke.Metabolic health is more closely associated with prevalence of cardiovascular diseases or stroke than obesity: A cross-sectional study in Korean populations.Prognostic Value of Admission Blood Glucose in Diabetic and Non-diabetic Patients with Intracerebral Hemorrhage.Stroke prevention: modifying risk factorsPsychoneuroimmune implications of type 2 diabetes: reduxReducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives.Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: a systematic review and meta-analysis.Clinical predictors and management of hemorrhagic transformation.Role of dietary and endogenous antioxidants in diabetes.Higher C-peptide levels are associated with regional cortical thinning in 1093 cognitively normal subjects.A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack.Post-Glucose Load Measures of Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke.Blood-Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke.Edaravone offers neuroprotection for acute diabetic stroke patients.Hyperinsulinaemia in migraineurs is associated with nitric oxide stress.[Atherosclerosis and uremia: signifance of non-traditional risk factors].Insulin resistance and risk of cerebral infarction in a Japanese general population: the Jichi Medical School Cohort Study.Association of the mitochondrial DNA 16189 T to C variant with lacunar cerebral infarction: evidence from a hospital-based case-control study.Insulin resistance in migraineurs: results from a case-control study.Report of the 20th European Stroke Conference, Hamburg, May 24-27, 2011.
P2860
Q26744840-0529DF45-722A-44D0-A639-D1DB0C0BF923Q30157712-7AEBE0AF-F144-4871-A03F-D8DF56678614Q34552287-BE1CB889-4C24-403C-9918-8BD2B0ECD3A1Q34625239-E9C39709-3D96-43D3-9007-3F0C0FA0E616Q34805939-EC50C9F6-3126-4753-8A89-DC83658C6650Q35238348-8A47A688-8B2B-411A-B6E7-0939BF6965A7Q35580956-3829F6CE-2AAE-45E8-B18A-C79062093099Q35581272-A9954AB1-1E9C-497A-9131-62364F573D4EQ36087568-CB39ECD0-EB49-48A1-8B54-269B8B83F973Q36100715-813B97A3-85F2-4327-825D-1B75569E805CQ36123467-91855F28-2A29-4B71-A9CA-DFA36A4CC45BQ36341789-59B3439D-828C-474F-B084-69FEEA64743FQ36402230-EAD34342-D4C2-4790-BDE4-41D27A96EB05Q36568506-51789A30-A578-4811-AA71-3887F380268CQ36663152-25723705-C0E4-4C20-BEBF-F57A1F714F2AQ36748171-C482C745-2F3C-47C2-8724-2019A7237C2EQ36934483-B883D03E-EAF1-4AAA-87D2-AB7756E68AB9Q36953272-FA78A380-27AA-45EE-A8D6-438DF751A0A3Q37119295-844A1180-50B5-4A6D-B314-3D552D7CDDFFQ37148345-3D8A32E2-C42B-4990-8DF9-74452DAA3013Q37153566-8A087B14-AEF6-460E-ADF8-C31F2B65DF2FQ37205723-4E6F613C-466C-4948-A697-38E22790DA02Q37208904-CA8701CB-1A56-4332-9ABF-037740C358C5Q37311198-84CC95CC-A283-4FD2-9113-74F5A92955C0Q37336959-74BDC25A-33DC-4514-B8CF-D512281DF3DBQ37462316-E7C46D51-12A9-43E7-AFC6-B21D89D642B1Q37576689-CB732360-2B13-41D7-AD44-1BCEC72C334AQ38074569-1C21010D-F18C-4825-8761-1A23803BE7A1Q38192085-10B43CA5-CC31-4413-A145-898761E3D301Q38436596-CFECDCB9-1939-4E64-8ABF-C47B39CE6E3AQ38881010-C761A91A-BFEB-42C4-BD4C-37C010AB91DDQ39008928-0F43F87E-0F87-4281-BAAF-5156A4740D2AQ39345035-83E90152-7513-43D1-AEE2-B97935B472E7Q40898682-7AEDBE19-EEF4-443D-A15D-754C95F1E4A3Q43279152-7B488648-93BB-49C6-892F-07D4725C52A6Q44460931-2A85719B-9F4B-4B3B-AFA0-FCE648AD2426Q44723553-4986FB63-C383-48E0-815D-5A05A253D43BQ44883081-5C5BD0D6-F087-4ED3-9A3C-26CBC0448808Q44913585-9DEF53BD-5E78-4F39-A3C8-6FC3A542EBC1Q45780089-845E77FE-830D-4E02-A58E-3C547AE73E56
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin resistance and risk for stroke.
@ast
Insulin resistance and risk for stroke.
@en
Insulin resistance and risk for stroke.
@nl
type
label
Insulin resistance and risk for stroke.
@ast
Insulin resistance and risk for stroke.
@en
Insulin resistance and risk for stroke.
@nl
prefLabel
Insulin resistance and risk for stroke.
@ast
Insulin resistance and risk for stroke.
@en
Insulin resistance and risk for stroke.
@nl
P2093
P356
P1433
P1476
Insulin resistance and risk for stroke.
@en
P2093
P304
P356
10.1212/WNL.59.6.809
P407
P577
2002-09-01T00:00:00Z